Home › Urothelial (Transitional Cell) Carcinoma › Massachusetts › Boston

Pag-aaral pangklinika para sa Urothelial (Transitional Cell) Carcinoma sa Boston, MA

Isang pag-aaral para sa Urothelial (Transitional Cell) Carcinoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Boston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Nagre-recruitPhase 1

Exelixis Clinical Site #7, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05176483

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Nagre-recruitPhase 1

Brigham and Women's Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07090499

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

Nagre-recruitObservasyonal na pag-aaral

Mass General Brigham, Boston
Brigham and Women's Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05874921

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Nagre-recruitPhase 1/2

Tufts Medical Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Nagre-recruitPhase 3

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07218380

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Nagre-recruitPhase 1

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06293898

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06966024

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Nagre-recruitPhase 3

Research Site, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT07720284

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 2, 2026 · NCT06451497

Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

Nagre-recruitObservasyonal na pag-aaral

Dana-Farber Cancer Institute, Boston

Edad 65 pataas · Lahat ng kasarian · Na-update Peb 17, 2026 · NCT06138561

Sacituzumab Govitecan Plus EV in Metastatic UC

Nagre-recruitPhase 1/2

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2025 · NCT04724018

Pag-aaral para sa Urothelial (Transitional Cell) Carcinoma sa ibang lungsod

Iba pang pag-aaral sa Boston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.